Supernus Pharmaceuticals Files 8-K on Director Changes
Ticker: SUPN · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1356576
| Field | Detail |
|---|---|
| Company | Supernus Pharmaceuticals, Inc. (SUPN) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: SUPN
TL;DR
Supernus Pharma 8-K: Board shuffle and exec comp updates filed Feb 24.
AI Summary
On February 24, 2025, Supernus Pharmaceuticals, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing includes the election of new directors and updates to compensatory arrangements for certain officers, though specific names and dollar amounts related to these changes are not detailed in the provided excerpt.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — The filing is routine and reports on corporate governance matters without immediate financial implications.
Key Players & Entities
- Supernus Pharmaceuticals, Inc. (company) — Registrant
- February 24, 2025 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates the election of directors and departure of directors, but the specific names of individuals are not provided in this excerpt.
What are the details of the updated compensatory arrangements?
The filing mentions updates to compensatory arrangements for certain officers, but the specific details and amounts are not included in this provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on February 24, 2025.
What is the principal executive office address for Supernus Pharmaceuticals, Inc.?
The principal executive offices are located at 9715 Key West Ave, Rockville, MD 20850.
What is the SIC code for Supernus Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code is 2834 for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding SUPERNUS PHARMACEUTICALS, INC. (SUPN).